Alphatec (NASDAQ:ATEC) Rating Reiterated by Needham & Compan

Alphatec (NASDAQ:ATEC – Get Rating)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued on Monday, Benzinga reports. They currently have a $18.00 price objective on the medical technology company’s stock. Needham & Company LLC’s price target would indicate a potential upside of 14.87% from the company’s previous […]

Related Keywords

Jamesll Tullis , , Securities Exchange Commission , Leverage Partners Absolute Return Fund , Alphatec Company Profile , First Light Asset Management , Waypoint Capital Advisors , Alphatec Holdings Inc , Jump Financial , Morgan Stanley , Needham Company , Get Rating , Lake Street Capital , Exchange Commission , Director James , Light Asset Management , Capital Advisors , Global Management , Alphatec Daily , Alphatec , Nasdaq Atec , Zatec , Medical , 02081g10 , Reiterated Rating , Needham Company Llc ,